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Cognitive impairment among type-2
diabetic subjects and its relationship with
long-term complications
Aim: Studies about relationships between diabetes mellitus, diabetic complications, and cognitive
functions have been initiative factors for this study. We evaluated various relations between procedure
of the disease, diabetic complications, and cognitive functions among diabetic subjects.
Materials and methods: Type-2 diabetic patients were evaluated for their disease status,
complications, and cognitive functions (by Mini Mental State Examination (MMSE) test). We
compared MMSE results of the patients with the control group.
Results: We evaluated 75 patients with type-2 diabetes mellitus and 49 control subjects. Orientation
(P = 0.006), attention and calculation (P = 0.002), and total (P < 0.001) scores of the control group
were significantly greater compared to the diabetic group. We observed negative correlation between
the length of disease and cognitive functions within the diabetic group. Recall scores of the diabetic
subjects with 6 and less HBAIC levels were significantly greater than those with 6.1 and greater levels
(P = 0.049). We observed negative relations between registration scores and retinopathy, but not
between orientation and total scores and hypertension among diabetic subjects.
Conclusion: Type-2 diabetes mellitus may destroy cognitive function. Length of disease, high serum
HBAIC levels, hypertension, and retinopathy are significant additional risk factors. We conclude that
cognitive function assessment should be routine procedure in the management of type-2 diabetes
mellitus.
Key words: Diabetes Mellitus, cognitive impairment, retinopathy, hypertension

Tip 2 diyabetli kişilerde kognitif bozulma ve uzun süreli
komplikasyonlarla ilişkisi
Amaç: Diabetes Mellitusta, diyabetik komplikasyonlar ve kognitif fonksiyonlar arasındaki ilişkileri
konu alan çalışmalar çalışmamızın ilham kaynağı olmuştur. Bu çalışmada, Diyabetik hastalarda
hastalık sürecinin ve komplikasyonlarının kognitif fonksiyonlar ile olan çeşitli ilişkilerini araştırdık.
Yöntem ve gereçler: Tip 2 diyabetli hastalar, hastalıklarının durumu, diyabetik komplikasyonlar ve
kognitif fonksiyonları (Mini Mental Durum İncelemesi ile ) yönünden incelendi . Hastaların
sonuçları kontrol grubu ile karşılaştırıldı.
Bulgular: Çalışmada, 75 diyabetik hasta ve 49 kontrol vakasını inceledik. Kontrol grubunun
“Oryantasyon” (P = 0,006), “Dikkat ve Hesaplama” (P = 0,002), ve “Toplam” (P < 0,001), skorları
diyabetik grubunkilerden anlamlı olarak yüksek idi. Diabetik hastalarda “Hastalık süresi” ile çeşitli
kognitif fonksiyonlar arasında negative korelasyonlar saptadık. HBAIC düzeyleri 6 ve daha düşük
olan diyabetik hastaların “Hatırlama” skorları, HBAIC düzeyleri 6.1 ve daha yüksek olanlarınkinden
daha yüksek idi (P = 0,049). Diyabetli hastalarda ayrıca “Kayıt” skorları ile Retinopati komplikasyonu
arasında, “Oryantasyon” ve “Toplam” skorlar ile hipertansiyon arasında olumsuz ilişkiler gözledik.
Sonuç: Tip 2 Diabetes Mellitus, kognitif fonksiyonları olumsuz yönde etkileyebilir. Hastalığın süresi,
yüksek serum HBAIC seviyeleri, hipertansiyon ve retinopati belirgin ek risk faktörleridir. Tip 2
diabetes Mellitusun yönetiminde kognitif fonksiyon incelenmesi rutin bir işlem olmalıdır.
Anahtar sözcükler: Diabetes mellitus, kognitif bozukluk, retinopati, hipertansiyon

oguztekin82@hotmail.com
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Introduction
Relations between mental function impairments
and some chronic diseases have been researched
previously. Cognitive functions may be influenced by
various factors. Diseases or conditions that destroy
vascular circulation or brain metabolism may lead to
cognitive impairment. In some articles, chronic
hypoglycemia has been observed to be responsible for
cognitive impairment in type-1 diabetic subjects
based on retinopathy (1). Within type-1 diabetic
patients, chronic recurrent hypoglycemia may lead to
cognitive impairment among subjects with peripheral
polyneuropathy (2). However, in another study,
chronic recurrent hypoglycemia alone was never
found as a risk factor for cognitive impairment (3).
Relevance of cognitive impairment has increased
when APOE epsilon 4 genotype based on type-1
diabetes mellitus (DM) was present (4). Visual
functions (visual reaction time) have been destroyed
by both hypoglycemia (50 mg/dL) and hyperglycemia
(300 mg/dL) in type-1 diabetic subjects (5). Diabetic
retinopathy and polyneuropathy both led to the
limited cognitive impairment in the Type-1 DM even
in the absence of the diabetic encephalopathy (6).
Complications of DM may be micro vascular
(retinopathy, nephropathy, and neuropathy) (7) or
macro vascular (hypertension) (8), as well. Diabetic
retinopathy may be classified as nonproliferative
(background) and proliferative. Constitutional
vascular changes, retinal hypo perfusion and edema,
and intraregional hemorrhages are essential
components of nonproliferative (background)
retinopathy. Neovascularization is the cornerstone of
the proliferative changes.
Mini Mental State Examination (MMSE or
Standardized Mini Mental Test) is very effective
method frequently used for assessment of cognitive
function. MMSE observes 5 departments of cognitive
function (orientation, recall, registration, attention
and calculation, language) (9, 10) (Figure 1).
In this study we aimed to research cognitive
function impairments of Type 2 DM subjects because
it is a very frequent disease encountered in daily
practice. We also aimed to research the effects of the
duration of disease, long-term complications, and
glycemic control on these functions. With a
662
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comprehensive approach, we may achieve more
effective management of DM by determining patients’
cognitive functions.
Materials and methods
Subjects
This was an observational, case-control, and
analytical study approved by the Ethical Committee
of the University. Data were collected from patients
in Family Medicine, Neurology an Ophthalmology
clinics of Fatih University hospital in Ankara, Turkey.
Subjects (older than 40 years) with Type-2 DM were
evaluated between 2002 and 2007. We evaluated
patients’ records consecutively in this time period. A
detailed history of all patients (age, gender,
educational level (years of schooling), history of
diabetic complications (hypertension, nephropathy,
neuropathy, etc), medications, confounding diseases
(especially neurological), and any condition that may
have effects on mental status were recorded. Type of
anti-diabetic medication (insulin or oral agents),
serum HBAIC levels (mean of multiple HBAIC
records were used, if possible) and the length of
disease of diabetic patients were recorded. We
performed a detailed physical examination, routine
biochemistry screening including renal, hepatic
function tests. Serum TSH and vitamin B12 levels of
the subjects were also determined, if necessary,
according to the clinical data.
Inclusion criteria were: age 40 years and older,
Type-2 DM with no accompanying disease, and no
other condition or medication affecting the mental
status. Exclusion criteria were: existence of any other
disease or use of any medication that may affect
mental functions negatively except diabetic
complications (Parkinson’s disease, some medications,
etc), any condition that may impair cognitive
functions (depression, hypothyroidism, vitamin B12
deficiency, electrolyte disturbance, hepatic diseases,
etc).
We also formed a control group with subjects in
the same age margins without any chronic disease,
chronic medication, or chronic hazardous habits.
Evaluation of subjects was performed by family
medicine, ophthalmology, and neurology specialists.
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Mini Mental State Examination
Maximum
Score
Score
Orientation
5
------ What is the Year Season Month Date Day
5
------ Where are we State County Town or City Building Floor
Registration
3
------- Name three common objects. (Pencil, clock, apple etc) Then ask the patient
to repeat all after you have said them
Give one point for each correct answer. (Give 20 seconds)

Attention and Calculation
5
-------Count back from 100 by subtracting 7 for each step. (100, 93, 86 etc). Give
one point for each correct calculation.
Recall
3
---------- Ask for the three objects repeated above. Give one point for each correct
answer. (Give 20 seconds)
Language
2
--------- Name two objects you saw (Clock, pen)
1
---------- Repeat the following: "No ifs, ands or buts."
3
---------- Follow three command after listening (Give one point for each correct
movement)
1
----------- Read the sentence and follow
1
---------- Write a meaningful sentence
1
---------- Copy the following design
Total
30

---------

Figure 1. Mini Mental State Examination of Folstein (Modified by Molley and Standish).

The person who performed MMSE was blinded with
the respect to the clinical (diabetic) features;
ophthalmologist was also blinded with respect to the
MMSE test results.
Determination of retinopathy
We performed ophthalmologic examination in the
patients and evaluated fundus changes of them in 4
main categories: background, preproliferative,
proliferative, and maculopathy. Patients were divided
into 2 main groups according to the examination:
diabetic with retinopathy and diabetic without any
retinopathy.
Determination of peripheral neuropathy
Clinical history and/or electroneurographic
examination results, which were performed by a
neurologist, were used for records.

Determination of cognitive function
We screened all subjects with the Mini Mental
State Examination (MMSE), which is widely used in
cognitive function assessment. MMSE scores were
evaluated in 5 categories: orientation (10 points),
registration (3 points), attention and calculation (5
points), recall (3 points), language (9 points), and total
(30 points) (Figure 1).
We also performed further tests (serum vitamin
B12 level, TSH, and Hamilton’s depression test) and
Cranial Computerized Tomography or Magnetic
Resonance Imaging to the subjects according to their
clinical data whenever we observed that MMSE scores
were less than 24.
Statistical analysis
We analyzed the differences in the means of
continuous measurements of MMSE by the Mann663
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Whitney U test and Student’s T test between groups.
We performed binary logistic regression between
control and diabetic groups to analyze total scores of
MMSE. ANCOVA (Factorial ANOVA) was
performed for correction of age and educational
levels. Multivariate analyses (Pearson correlation) for
educational status, duration of disease, and MMSE
scores were also performed. A P value of <0.05 was
considered to indicate statistical significance; all tests
were 2-tailed and in the 95% confidence interval.

Turk J Med Sci

30
28
Total SMMT scores

TEKİN, O et al.

26
24
22
20
18
16

Results
Control Group n= 49

Exclusion
In this study, we evaluated 94 patients, 19 of them
were excluded for various reasons (5 for depression, 4
for hypothyroidism, 3 for hepatic diseases, 3 for
vitamin B12 deficiency, 4 for neurological diseases).
We included 75 subjects (35 men and 40 women) into
the study. Control group was constituted by 49
subjects.
Patient characteristics
Twenty one patients were treated with insulin &
insulin + oral antidiabetic (28%) and 54 received oral
antidiabetic (72%). Forty four patients (58.7%) had
hypertension and 16 had (21.3%) ischemic heart

Table.1

Parameter
Gender
Men
Women
Age
Treatment
OAD
Insulin & Insulin +OAD

664

Diabetes Mellitus n= 75

Figure 2. Comparison of total MMSE scores of control group and
DM group.

disease. Other micro vascular and macro vascular
features are outlined in Table 1.
Comparison of the MMSE scores among control
group and diabetic subjects generally
Means of the MMSE categories of the control
group and diabetic patients are displayed in Table 2.
Orientation (P < 0.001), registration (P = 0.026),
attention and calculation (P < 0.001), recall (P =
0.030) and total(P < 0.001) scores of the control group

Demographic data of the subjects
Control

DM

n (Percent) & mean ± SD

n (Percent) & mean ± SD

29 (59.2)
20 (40.8)

35 (46.7)
40 (53.3)

54.7 ± 8.46

57 ± 8.1

54 (72)
21 (28)

Retinopathy
Hypertension
Nephropathy
Ischaemic Heart d.
Peripheral neuropathy

30 (40)
44 (58.7)
17 (22.7)
16 (21.3)
33 (44)

Length of Disease

8.3 ± 5.9
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Table 2. Comparison of the Mini Mental State Examination scores of groups generally.
Control

Diabetes Mellitus

SMMT Category

N

Mean

N

Mean

P

Orientation

49

9.73 ± 0.60

75

8.83 ± 1.6

< 0.001**

Registration

49

2.96 ± 0.2

75

2.77 ± 0.67

0.026*

Attention and Calculation

49

4.35 ± 1.33

75

3.2 ± 1.99

< 0.001**

Recall

49

2.06 ± 0.89

75

1.67 ± 1.08

0.030*

Language

49

8.5 ± 0.65

75

8.2 ± 1.09

0.050

Total

49

27.6 ± 1.09

75

24. 6 ± 3.8

< 0.001**

were statistically higher compared to the DM group
(Figure 1). We did not observe any age difference
among groups (P > 0.05). However, we observed
significant difference regarding educational status
(Means; Control: 7.45 ± 4.3 DM: 5.28 ± 4.0, P =
0.005). Therefore, we performed ANCOVA test for
correction of the results according to the age and
educational status. Then, we observed significant

Table 3.

differences regarding orientation (P = 0.006),
attention and calculation (P = 0.002), and total (P <
0.001) scores among groups this time.
We categorized the total scores as “24 and less” and
“greater than 24” (significant cut-point for dementia)
(Table 3). In the logistic regression analysis, the DM
group was 7.2 times more relevant than the control
group for cut-point of the total score.

Comparison of cut-off points of total standardized
mental test scores of groups generally.
Total SMMT points

Groups

24 and less

greater than 24

DM (n, percent)

33 (44)

42 (56)

Control (n, percent)

4 (8.2)

45 (91.8)

P < 0.001
Table 3A. Logistic Regression output according to the cut-point of Total MMSE scores among Control and DM groups.

Coefficient

s.e.

Wald

P

OR

95 % CI for OR

DM

1.983

0.581

11.628

0.001 **

7.262

2.324 to 22.698

Age

- 0.017

0.026

0.438

0.508

0.983

0.933 to 1.035

Year of Schooling

0.111

0.057

3.733

0.053

1.117

0.998 to 1.250

Constant

0.671

1.597

0.176

0.675

1.955

665
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We observed negative correlations between length
of disease and orientation scores (Pearson correlation
coefficient = -0.250 P=0.032), and between length of
disease and total scores (Pearson correlation
coefficient = -0.248, P = 0.032) whereas positive
correlations were observed between educational status
and orientation (Pearson correlation coefficient =
0.378, P = 0.001), and between educational status and
total scores (Pearson correlation coefficient = 0.350, P
= 0.002) in the DM group (Figure 3).
In the “Control” group, we observed negative
correlation between age and recall (Pearson
correlation coefficient = -0.605 P < 0.001) whereas
positive correlations between educational status and
orientation (Pearson correlation coefficient = 0.341 P
= 0.016), between educational status and language
(Pearson correlation coefficient = 0.399 P = 0.005),
and between educational status and total scores
(Pearson correlation coefficient = 0. 384, P = 0.006).

Turk J Med Sci

General evaluation of relationships between
complications and MMSE scores
We performed ANCOVA test among the DM
group to determine the relations between
complications and all MMSE scores based on the
corrected values of the factors. We observed
significant relations between orientation scores and
hypertension, between registration scores and
retinopathy, between total scores and hypertension
(Table 4 A, 4-B, and 4-C).
Comparison of the MMSE scores of DM cases
according to the long-term complications

Comparison of the MMSE scores among DM
cases according to the HBAIC levels

We compared orientation and total scores of DM
patients without hypertension (n = 31) and DM
patients with hypertension (n = 44) (Means = 9.35 ±
1.14, 8.45 ± 1.77, P = 0.010 and 25.8 ± 2.5, 23.8 ± 4.3,
P = 0.013, respectively). We also compared
“registration” scores of DM patients without
retinopathy (n = 45) and DM patients with
retinopathy (n = 30) (Means = 2.96 ± 0.29, 2.5 ± 0.94,
P = 0.015, respectively).

We categorized DM cases according to their serum
HBAIC levels. We formed 2 groups, namely group 1
(HBAIC levels 6 and less, n=8) and group 2 (HBAIC
levels 6.1 and greater, n=67). All scores of the group 2
were lower than those of group 1. However, recall
scores of the groups were statistically different (Means
= 2.38 ± 0.744, 1.58 ± 1.09, P = 0.049) (Figure 4). We
never observed any difference for age, educational
status, and length of the disease among groups.

We categorized DM cases according to the
effective complications status (group 1= Cases
without hypertension or retinopathy, n =19; group 2
= Cases with any of these complications, n = 56). We
did not observe any significant difference of age or
educational status between groups. However, we
observed a significant difference regarding the total
scores (group 1 = 25.9 ± 2.5, group 2 = 24.2 ± 4.0, P =
0.032). Furthermore, we also compared the control

3

14

2.5

Educational Level

12

Recall Scores

10
8

1.5

6
4

1

0.5

2
0

0

16

18

20
22
24
26
Total SMMT scores

28

30

Figure 3. Correlation between Total MMSE scores and
educational level among patients with Type-2 DM.
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2

Group 1

Group 2

Figure 4. Comparison of recall scores among groups according to
HBAIC levels.
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Table 4A. Relations between diabetic complications and orientation scores.
Dependent Variable: Orientation
Group Source
DM

Type III Sum of Squares

df

Mean Square

F

Sig.

42.83 (a)

7

6.119

2.810

0.013

Intercept

57.674

1

57.674

26.482

.000

Retinopathy

2.023

1

2.023

0.929

NS

Hypertension

11.122

1

11.122

5.107

0.027

Nephropathy

0.045

1

0.045

0.021

NS

Corrected Model

Ischaemic H. Disease

1.319

1

1.319

0.606

NS

P. Neuropathy

0.244

1

0.244

0.112

NS

Age

0.134

1

0.134

0.061

NS

Educational Level

21.993

1

21.993

10.099

0.002

Error

145.916

67

2.178

Total

6032.000

75

Corrected Total

188.747

74

(a) R Squared = .227 (Adjusted R Squared = .146)

Table 4B. The relation between diabetic complications and registration scores.
Dependent variable: registration
Group Source
DM

Type III Sum of Squares

df

Mean Square

F

Sig.

6.665(a)

7

0.952

2.409

0.029

Intercept

10.792

1

10.792

27.304

.000

Retinopathy

3.211

1

3.211

8.124

0.006

Hypertension

0.039

1

0.039

0.098

NS

Nephropathy

1.722

1

1.722

4.357

NS

Ischaemic H. Disease

0.007

1

0.007

0.017

NS

P. Neuropathy

0.572

1

0.572

1.448

NS

Age

0.387

1

0.387

0.978

NS

Educational Level

0.252

1

0.252

0.638

NS

Error

26.482

67

.395

Total

610.000

75

Corrected Total

33.147

74

Corrected Model

(a) R Squared = .201 (Adjusted R Squared = .118)
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Table 4C. Relations between diabetic complications and total mmse scores.
Dependent variable: total
Group Source
DM

Type III Sum of Squares

df

Mean Square

F

Sig.

250.726(a)

7

35.818

2.945

0.009

719.985

1

719.985

59.202

.000

Retinopathy

3.239

1

3.239

0.266

NS

Hypertension

52.201

1

52.201

4.292

0.042

Nephropathy

12.341

1

12.341

1.015

NS

Corrected Model
Intercept

Ischaemic H. Disease

0.530

1

0.530

0.044

NS

P. Neuropathy

33.035

1

33.035

2.716

NS

Age

14.792

1

14.792

1.216

NS

Educational Level

73.147

1

73.147

6.015

0.017

Error

814.821

67

12.162

Total

46551.000

75

Corrected Total

1065.547

74

(a) R Squared = .235 (Adjusted R Squared = .155 )

group (n = 49) and group 1 (n = 19) , and we observed
significant differences for attention and calculation
scores (Means = 4.35 ± 1.3, 3.47 ± 1.8, P = 0.026) and
total scores between groups (Means = 27.6 ± 1.9, 25.9
± 2.5, P = 0.012).
Discussion
Comparison with previous findings
Studies about relationship between Type-1 DM
and cognitive function impairment were interesting.
In a previous study, frequent hypoglycemic attacks
have been displayed to destroy the attention and recall
functions based on background retinopathy (1). In
another study, retinopathy and peripheral neuropathy
have been displayed to affect the cognitive function
limitedly (6). In our study, cognitive functions
(orientation, attention and calculation, total) are
influenced in the Type-2 diabetic patients; however,
these impairments were more severe in the existence
of some long-term complications, such as retinopathy
and hypertension.
In another study, recurrent hypoglycemia has been
displayed to effect cognitive function in the existence
of distal symmetric neuropathy (2). However, in our
668

study we did not observe any difference for cognitive
functions among cases with or without neuropathy.
For this reason, we believe that peripheral neuropathy
is never an additional risk for cognitive impairment
in Type-2 DM.
In one study, effects of long-term glycemic control
on cognitive function has been observed and negative
effects of excessive glycemic changes on visual
functions of the brain have been observed (5). In our
study, cut-off point of HBAIC (Reflecting long-term
glycemic control) for significant effect on cognitive
function (recall) was 6.1 (Figure 3). Here, negative
relation between the length of disease and cognitive
function (orientation and total) was an interesting
point that may show the hazardous effect of long-time
hyperglycemic blood levels on cognitive functions.
Clinical implications
It was obvious that Type-2 diabetic patients were
under serious risk for cognitive impairment.
Especially, poor glycemic control, retinopathy,
hypertension, and longer disease periods are
significant additional risk factors.
It would be useful observing cognitive functions
as well as obtaining good glycemic control and
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observing micro-macro vascular complications in the
management of diabetes mellitus. Any cognitive
decline may be detected by periodical mental
examinations and further investigations may be
performed. We believe that diabetic patients with
retinopathy, hypertension, and longer disease period
or with serum levels of HBAIC greater than 6.1 should
be examined much more frequently.
Treatment of detected cognitive decline and
preventive studies should be planned by more ample
studies in the future. Results of our recent study may
address risks easily and cost-effectively for cognitive
declining among Type-2 diabetic patients.

October 2009

Conclusions and recommendations
Type-2 diabetic patients are under great risk for
cognitive decline. This risk is more relevant in the
existence of retinopathy, hypertension, long disease
period, and high HBAIC levels. Frequent assessment
of cognitive functions in diabetic subjects, especially
in the mentioned situations above, preventive
approach, and treatment studies should be performed.
We conclude that cognitive function evaluation
should be a routine procedure in the management of
Type-2 DM.
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